U.S. CDC Says Will Enhance Screening And Monitoring Of Travelers Arriving From Areas Affected By Ebola Outbreaks; Will Coordinate With Airlines, Others To Manage Travelers Who May Have Already Been Exposed To Ebola; Will Enhance Contract Tracing, Hospital Readiness Nationwide
Ginkgo Bioworks Holdings Inc DNA
$8.32
▲ +2.97%
(+$0.24)
Open
$8.13
Prev Close
$8.08
Day Range
$8.13 – $8.39
52W Range
$5.37 – $17.58
Market Cap
$523.32M
Beta
1.74
EPS (TTM)
$-5.64
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2021-04-19 |
| Shares Out. | 62,320,000 |
| Website | investors.ginkgobioworks.com/ ↗ |
| Phone | 18774425362 |
Ginkgo Bioworks Holdings Inc is a publicly traded company under the ticker symbol DNA on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-05-01)
📰 Latest News for DNA
Ginkgo Bioworks Holdings, Inc. 2026 Q1 - Results - Earnings Call Presentation
The Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Have Been Trimming Their Sales Forecasts
Ginkgo Bioworks: Another Lost Year
How The Ginkgo Bioworks (DNA) Story Is Shifting After The Biosecurity Divestiture And Target Cut
Ginkgo Bioworks Q1 Earnings Call Highlights